Substance / Medication

Dopamine

Overview

Active Ingredient
dopamine
RxNorm CUI
3628

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Preclinical and clinical sex differences in the effects of alcohol on measures of brain dopamine: a systematic review.
Barrios Nathalie, Riordan Will, Garcia-Rivas Vernon et al. · Biol Sex Differ · 2025
PMID: 40200334Meta-AnalysisFull text (PMC)
Efficacy and Safety of VMAT-2 Inhibitors and Dopamine Stabilizers for Huntington's Chorea: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
Floridia Rietmann Lautaro Manuel, Romano Candela, Beltrán Covarrubias Salma Alejandra et al. · Med Sci (Basel) · 2025
PMID: 41003150Meta-AnalysisFull text (PMC)
Dopamine in Tourette syndrome: a 30-year bibliometric analysis of hotspot evolution.
Liu Qian, Zhu Zhiyao, Luo Fei et al. · Front Neurol · 2025
PMID: 41041675Meta-AnalysisFull text (PMC)
Impulse control disorders in prolactinoma patients treated with dopamine agonists: a systematic review and meta-analysis with trial sequential analysis.
Penchev Plamen, Milanova-Ilieva Daniela, Gaydarski Lyubomir et al. · J Clin Neurosci · 2025
PMID: 40480033Meta-Analysis
Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.
Prates-Rodrigues Mateus, Schweizer Beatriz Lage Araújo, de Paula Gomes Clara et al. · J Neurochem · 2025
PMID: 39901598Meta-AnalysisFull text (PMC)
The effect of dopamine agonists on cardiometabolic risk factors: a systematic review and meta-analysis.
Xue Yizhuo, Sohouli Mohammad Hassan, Sernizon Guimarães Nathalia · Expert Opin Pharmacother · 2025
PMID: 40552576Meta-Analysis
The dual role of dopamine and serotonin in cancer progression and inflammation: Mechanisms and therapeutic potential.
Ahangari Ghasem, Norioun Hamid · Neuroscience · 2025
PMID: 39675693Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dopamine (substance)
SNOMED CT
412383006
UMLS CUI
C0013030
RxNorm CUI
3628

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

4
Conditions
1
Biomarkers
0
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.